NaDeNo is a close-to-clinic biotech with robust IPR and a strong team
Our team combines decade-long experience with the platform technology with deep industry expertise across clinical drug development.
By leveraging solid partners, NaDeNo is able to advance our lead candidate through clinical development while broadening the platform with attractive pipeline projects.
Team
Jens Bjørheim
Chief Medical Officer
Tore Kvam
Chief Financial Officer
Gudrun Trøite
Head of Operations
Erik Møller Steen
Project & Business Development Manager
Sofie Snipstad
Senior Scientist
Jan Håbrekke
Board Member
Annbjørg Falck
Co-founder & Chief Executive Officer
Yrr Mørch
Co-founder & Chief Technology Officer
Board of Directors
Ole Dahlberg
Chair of the Board
Jostein Bjøndal
Board Member
Cristianne Rijcken
Board Member
Jonas Hallén
Board Member